We are live on
!
Find out more
GP
Grow Partners Portfolio holdings
AUM
$4.81M
1-Year Est. Return
7.86%
This Fund
S&P 500
This Quarter
Est. Return
+12.39%
1 Year Est. Return
+7.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
-$12.5M
(-7.6%)
Cap. Flow
-$14.4M
Cap. Flow
% of AUM
-9.49%
Top 10 Holdings %
Top 10 Hldgs %
60.36%
Holding
42
New
8
Increased
3
Reduced
9
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PLPM
Planet Payment, Inc
PLPM
|
+$13.2M |
| 2 |
DWCH
Datawatch Corp
DWCH
|
+$11.3M |
| 3 |
ICAD
iCAD Inc
ICAD
|
+$8.85M |
| 4 |
Cineverse
CNVS
|
+$4.72M |
| 5 |
AudioCodes
AUDC
|
+$3.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMPV
Imperva, Inc.
IMPV
|
+$13.1M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$7.86M |
| 3 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
+$6.59M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$5.8M |
| 5 |
COA
COASTAL CONTACTS INC COMMON SHARES (CANADA)
COA
|
+$4.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.17% |
| 2 | Healthcare | 27.62% |
| 3 | Industrials | 16.84% |
| 4 | Energy | 4.43% |
| 5 | Communication Services | 2.96% |
Similar funds
GH
STIA
RCM
BPCM
KC
AIM
NA
LSVI
Grow Partners's Q1 2014 Portfolio in Review
As of Q1 2014, Grow Partners held 42 positions worth $152M, down 7.6% from $164M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Grow Partners withdrew a net $14.4M in Q1 2014, closing 14 positions and reducing 9 holdings. Its most notable exit was Imperva, Inc., an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Grow Partners opened a new position in Planet Payment, Inc worth $10.8M.
- Grow Partners's largest Q1 2014 buy was Planet Payment, Inc: 3,960,000 shares worth $10.8M.
- Grow Partners added most to iCAD Inc in Q1 2014, an estimated $8.85M increase.
- Grow Partners's biggest Q1 2014 reduction was Ligand Pharmaceuticals, cutting an estimated $7.86M.
- Grow Partners fully exited Imperva, Inc. in Q1 2014, selling an estimated $13.1M.
- Grow Partners's ten largest holdings make up 60% of its $152M portfolio in Q1 2014.
- Grow Partners opened 8 new positions and closed 14 in Q1 2014.
- Grow Partners's portfolio value fell 7.6% quarter-over-quarter to $152M.
Based on Grow Partners's 13F filing for Q1 2014, filed 13 May 2014.